Get the Stockscreener App
11.98
4.36%
0.50
After Hours:
12.07
0.09
+0.75%
Instil Bio Inc stock is traded at $11.98, with a volume of 84,846.
It is up +4.36% in the last 24 hours and down -38.25% over the past month.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$11.48
Open:
$11.53
24h Volume:
84,846
Relative Volume:
0.71
Market Cap:
$81.25M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-1.0518
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
-1.80%
1M Performance:
-38.25%
6M Performance:
-43.01%
1Y Performance:
-52.89%
1-Day Range:
$11.26
$12.38
1-Week Range:
$11.26
$13.50
52-Week Range:
$10.80
$42.79
Instil Bio Inc Stock (TIL) Company Profile
Name
Instil Bio Inc
Sector
Industry
Phone
(972) 499-3350
Address
3963 MAPLE AVENUE, DALLAS
Compare TIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
11.98 | 77.86M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Jefferies | Hold → Buy |
| Nov-04-24 | Initiated | JMP Securities | Mkt Perform |
| Apr-12-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-22 | Downgrade | Truist | Buy → Hold |
| Aug-13-21 | Initiated | Robert W. Baird | Outperform |
| Apr-13-21 | Initiated | Cowen | Outperform |
| Apr-13-21 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-21 | Initiated | Truist | Buy |
View All
Instil Bio Inc Stock (TIL) Latest News
Instil Bio Inc (TIL) looking to reclaim success with recent performance - Setenews
Understanding the Setup: (TIL) and Scalable Risk - news.stocktradersdaily.com
Why Instil Bio Inc. stock is a value investor pickMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Is Instil Bio Inc. showing signs of accumulation2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
Working capital per share of Instil Bio, Inc. – FWB:5GT0 - TradingView
Instil Bio, Inc. Balance Sheet – FWB:5GT0 - TradingView
Signal strength of Instil Bio Inc. stock in tech scanners2025 Year in Review & Growth Oriented Trade Recommendations - newser.com
Will Instil Bio Inc. stock maintain momentum in 2025Portfolio Gains Report & Proven Capital Preservation Methods - newser.com
How Instil Bio Inc. stock reacts to job market data2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Is Instil Bio Inc. stock attractive for long term wealth buildingJuly 2025 Patterns & Expert Curated Trade Setups - newser.com
What hedge fund activity signals for Instil Bio Inc. stockQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Citizens reiterates Market Perform rating on Instil Bio stock By Investing.com - Investing.com Australia
Applying Wyckoff theory to Instil Bio Inc. stockPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-11-19 03:08:52 - newser.com
Citizens reiterates Market Perform rating on Instil Bio stock - Investing.com
What to expect from Instil Bio Inc. in the next 30 daysJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com
Published on: 2025-11-16 10:13:27 - newser.com
Applying big data sentiment scoring on Instil Bio Inc.July 2025 Fed Impact & Daily Chart Pattern Signal Reports - newser.com
Will Instil Bio Inc. stock benefit from automationIPO Watch & Advanced Swing Trade Entry Plans - newser.com
Heatmap analysis for Instil Bio Inc. and competitors2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com
Can Instil Bio Inc. stock maintain growth trajectoryJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Evaluating Instil Bio Inc. with trendline analysisQuarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com
Can Instil Bio Inc. stock deliver consistent earnings growth2025 Top Gainers & Daily Volume Surge Signals - newser.com
Instil Bio Inc Stock (TIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.76%
2.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):